You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-EBAG9 antibody (ab52042)

CodeSizePriceAbpointsAvailability
    
Add to basket
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-EBAG9 antibody
See all EBAG9 products (7) ...

Description

Rabbit polyclonal to EBAG9

Tested applications

IHC-Pmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide corresponding to C terminus of human EBAG9.

Epitope

C terminal.

Positive control

Human breast carcinoma.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.1% Sodium Azide
Constituents: 1% BSA, 10mM PBS, pH 7.4

Concentration

Concentration information loading...

Purification notes

ab52042 is affinity purified.

Clonality

Polyclonal

Isotype

IgG

Research areas

Cancer >> Tumor biomarkers >> Tumor antigens
Cancer >> Tumor immunology >> Tumor-associated antigens
Signal Transduction >> Growth Factors/Hormones >> Hormones
Tags & Cell Markers >> Cell Type Markers >> Tumor Associated

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - EBAG9 antibody (ab52042)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - EBAG9 antibody (ab52042) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab52042 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

IHC-P: 1/100 for 30 min at room temperature. Staining of formalin fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at room temperature for 20 min.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Relevance

EBAG9 is a type III transmembrane protein that is predominantly located in the Golgi. It induces apoptosis of natural killer (NK)/T cells and plays a role in immune invasion, possibly in relation to Epstein-Bar virus infection. EBAG9 is abundantly expressed in prostate cancer cells when compared to normal epithelial cells, and immunodetection of EBAG9 expression can be a negative prognostic indicator for patients with prostate cancer.

Cellular localization

Golgi apparatus; Golgi apparatus membrane; single pass type III membrane protein.

Alternative names

  • BAG9 antibody
  • Cancer associated surface antigen antibody
  • Cancer associated surface antigen RCAS1 antibody
  • EB9 antibody
  • EBAG 9 antibody
  • Estrogen receptor binding fragment associated gene 9 protein antibody
  • Estrogen receptor binding site associated antigen 9 antibody
  • PDAF antibody
  • RCAS 1 antibody
  • RCAS1 antibody
  • Receptor binding cancer antigen expressed on SiSo cells antibody
see all

Database links

Anti-EBAG9 antibody images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - EBAG9 antibody (ab52042)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - EBAG9 antibody (ab52042)

ab52042, at dilution of 1/100, staining EBAG9 in formalin fixed paraffin embedded human breast carcinoma tissue by Immunohistochemistry.

References for Anti-EBAG9 antibody (ab52042)

ab52042 has not yet been referenced specifically in any publications.

Publishing research using ab52042? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"